We are live on ! Find out more
HSA

Hussman Strategic Advisors Portfolio holdings

AUM $434M
1-Year Est. Return 19.64%
This Fund
S&P 500
This Quarter Est. Return
+8.02%
1 Year Est. Return
+19.64%
3 Year Est. Return
+41.56%
5 Year Est. Return
+34.45%
10 Year Est. Return
+261.65%
AUM
$434M
AUM Growth
-$28.5M
Cap. Flow
-$39M
Cap. Flow %
-8.97%
Top 10 Hldgs %
10.4%
Holding
334
New
66
Increased
40
Reduced
42
Closed
103

Top Buys

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$4.08M
2
UI icon
Ubiquiti
UI
+$3.96M
3
CRM icon
Salesforce
CRM
+$3.69M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.57M
5
GMED icon
Globus Medical
GMED
+$3.57M

Sector Composition

Rank Sector Weight
1 Healthcare 23.08%
2 Technology 17.18%
3 Consumer Discretionary 15.3%
4 Financials 9.77%
5 Consumer Staples 9.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PEP icon
1
PepsiCo
PEP
$188B
$5.12M 1.18%
37,800
+27,300
+260% +$4.08M
UI icon
2
Ubiquiti
UI
$35.1B
$5.05M 1.16%
9,450
+5,250
+125% +$3.96M
INCY icon
3
Incyte
INCY
$25.7B
$4.76M 1.1%
42,000
+10,500
+33% +$1.04M
VSAT icon
4
Viasat
VSAT
$10.4B
$4.72M 1.09%
52,500
-21,000
-29% -$1.39M
NBIX icon
5
Neurocrine Biosciences
NBIX
$15.8B
$4.6M 1.06%
27,300
+6,300
+30% +$935K
BIIB icon
6
Biogen
BIIB
$32.6B
$4.54M 1.05%
21,000
+14,700
+233% +$2.81M
HSY icon
7
Hershey
HSY
$34.8B
$4.42M 1.02%
25,200
+16,800
+200% +$3.17M
CMPR icon
8
Cimpress
CMPR
$2.13B
$4.27M 0.98%
42,000
+21,000
+100% +$1.87M
ZD icon
9
Ziff Davis
ZD
$1.91B
$3.85M 0.89%
73,500
+21,000
+40% +$950K
UNFI icon
10
United Natural Foods
UNFI
$2.66B
$3.84M 0.88%
84,000
-21,000
-20% -$1.04M
ULTA icon
11
Ulta Beauty
ULTA
$24.1B
$3.79M 0.87%
8,400
+1,050
+14% +$533K
CPB icon
12
Campbell Soup
CPB
$6.38B
$3.74M 0.86%
168,000
-42,000
-20% -$886K
GIS icon
13
General Mills
GIS
$20.5B
$3.65M 0.84%
105,000
+42,000
+67% +$1.45M
TDC icon
14
Teradata
TDC
$2.61B
$3.64M 0.84%
+105,000
New +$3.19M
DG icon
15
Dollar General
DG
$29.4B
$3.63M 0.84%
31,500
AEO icon
16
American Eagle Outfitters
AEO
$2.91B
$3.61M 0.83%
210,000
PACS icon
17
PACS Group
PACS
$6.73B
$3.58M 0.83%
+84,000
New +$3.02M
AUPH icon
18
Aurinia Pharmaceuticals
AUPH
$2.14B
$3.56M 0.82%
210,000
+126,000
+150% +$2.01M
SHOO icon
19
Steven Madden
SHOO
$3.2B
$3.54M 0.81%
84,000
PFS icon
20
Provident Financial Services
PFS
$3.09B
$3.48M 0.8%
+147,000
New +$3.3M
PRLB icon
21
Protolabs
PRLB
$1.95B
$3.42M 0.79%
42,000
-10,500
-20% -$739K
APA icon
22
APA Corp
APA
$15B
$3.42M 0.79%
105,000
NEM icon
23
Newmont
NEM
$135B
$3.42M 0.79%
36,600
+24,400
+200% +$2.66M
B
24
Barrick Mining
B
$73.7B
$3.36M 0.77%
91,500
+61,000
+200% +$2.5M
MCY icon
25
Mercury Insurance
MCY
$5.79B
$3.36M 0.77%
31,500
+10,500
+50% +$1.03M

Similar funds

Hussman Strategic Advisors's Q2 2026 Portfolio in Review

As of Q2 2026, Hussman Strategic Advisors held 334 positions worth $434M, down 6.2% from $463M the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Hussman Strategic Advisors withdrew a net $39M in Q2 2026, closing 103 positions and reducing 42 holdings. Its most notable exit was Corcept Therapeutics, an estimated $5.08M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 22% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Hussman Strategic Advisors opened a new position in Salesforce worth $3.29M.

  • Hussman Strategic Advisors's largest Q2 2026 buy was Salesforce: 21,000 shares worth $3.29M.
  • Hussman Strategic Advisors added most to PepsiCo in Q2 2026, an estimated $4.08M increase.
  • Hussman Strategic Advisors's biggest Q2 2026 reduction was Concentrix, cutting an estimated $2.74M.
  • Hussman Strategic Advisors fully exited Corcept Therapeutics in Q2 2026, selling an estimated $5.08M.
  • Hussman Strategic Advisors's ten largest holdings make up 10% of its $434M portfolio in Q2 2026.
  • Hussman Strategic Advisors opened 66 new positions and closed 103 in Q2 2026.
  • Hussman Strategic Advisors's portfolio value fell 6.2% quarter-over-quarter to $434M.

Based on Hussman Strategic Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.